Annual Drug Patent Expirations for LENVIMA Lenvima is a drug marketed by Eisai Inc and is included in one NDA. It is available from one supplier. There are seven patents…
Source
Annual Drug Patent Expirations for RUKOBIA Rukobia is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. There are three patents…
Source
This chart shows the drugs with the most patents in Eurasian Patent Organization. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…
Source
Which pharmaceutical drugs have the most drug patents in Eurasian Patent Organization? Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Luxembourg. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
Source
Which pharmaceutical companies have the most SPCs in Luxembourg? Read Post »
A paper presented at the 2nd International Conference on Systems Medicine, AI, and Drug Repurposing proposes a novel approach to overcoming the financial barriers associated with repurposing generic drugs through…
Source
Innovative Financing Models for Repurposing Generic Drugs Read Post »
Annual Drug Patent Expirations for ONGENTYS Ongentys is a drug marketed by Neurocrine and is included in one NDA. It is available from two suppliers. There are nine patents protecting…
Source
Annual Drug Patent Expirations for NEXLIZET Nexlizet is a drug marketed by Esperion Theraps Inc and is included in one NDA. It is available from one supplier. There are five…
Source
Annual Drug Patent Expirations for NEXLETOL Nexletol is a drug marketed by Esperion Theraps Inc and is included in one NDA. It is available from one supplier. There are three…
Source
Annual Drug Patent Expirations for OLINVYK Olinvyk is a drug marketed by Trevena and is included in one NDA. It is available from one supplier. There are four patents protecting…
Source
Annual Drug Patent Expirations for ARNUITY+ELLIPTA Arnuity Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are six patents…
Source
New patent for Glaxosmithkline drug ARNUITY ELLIPTA Read Post »
Get new actionable insights and updates from BiotechBlog
